Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Concordia University

$34,000.00

Understanding chiral amplification and chiral interactions in conglomerate crystals

EF 2016-17

Résumé
Louis Pasteur is best known for the process of 'pasteurization', typically associated with milk, but Pasteur's contribution to Chemistry is probably more far reaching. In 1848, Pasteur separated mirror image crystals of sodium ammonium tartrate based solely on visual inspection, and in the process inaugurated the intriguing topic of molecular asymmetry. Chirality, or handedness, is part of our everyday lives and its importance is particularly evident in the pharmaceutical industry, the agrochemical industry, and the food industry. The global market for chiral technology-enabled products is forecast to reach $5.1 billion by 2017. Chiral preference for one handedness of biomolecules is a characteristic of living systems, but the origin of biological homochirality is one of the outstanding mysteries facing scientists today and a precise explanation has yet to be found. A popular theory speculates that surfaces of chiral crystals such as quartz could have been the asymmetric influence that led to the origin of chiral molecules in the prebiotic world. Speculations such as these have drawn a great deal of attention towards chiral crystals. In our lab we are breaking mirror-symmetry and creating chiral crystals of only one handedness (homochiral) using a simple grinding technique. More importantly, we are able to steer the direction (or handedness) of mirror-symmetry breaking using chiral additives (e.g. left- or right-handed amino acids). The main objective of this research program is to investigate the phenomenon of directed mirror-symmetry breaking at the molecular level. We will use classic crystal growing techniques and modern instrumental and computational methods to study the interactions of chiral molecules with chiral crystals. Not only does this research have exciting implications regarding the origin of homochirality, but the interaction of organic molecules with crystalline materials is a continuously expanding research field for chemists, biochemists, and biologists (e.g. formation of bones, teeth, kidney stones and shells). Our work on chiral crystal grinding, may provide important insight into polymorphism and co-crystallization that play critical roles in the solid-state properties of pharmaceuticals.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2014-04616
Name nom
Cuccia, Louis
Department département
Chemistry and Biochemistry
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2014
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3402
Research subject group en
Physical chemistry
Research subject group fr
Chimie physique
Research subject en
Surface and interfacial chemistry
Research subject fr
Chimie des surfaces et des interfaces
Partie
3
Nb partie
5
Application title
Understanding chiral amplification and chiral interactions in conglomerate crystals
Keyword
NSERC
Application summary
Louis Pasteur is best known for the process of 'pasteurization', typically associated with milk, but Pasteur's contribution to Chemistry is probably more far reaching. In 1848, Pasteur separated mirror image crystals of sodium ammonium tartrate based solely on visual inspection, and in the process inaugurated the intriguing topic of molecular asymmetry. Chirality, or handedness, is part of our everyday lives and its importance is particularly evident in the pharmaceutical industry, the agrochemical industry, and the food industry. The global market for chiral technology-enabled products is forecast to reach $5.1 billion by 2017. Chiral preference for one handedness of biomolecules is a characteristic of living systems, but the origin of biological homochirality is one of the outstanding mysteries facing scientists today and a precise explanation has yet to be found. A popular theory speculates that surfaces of chiral crystals such as quartz could have been the asymmetric influence that led to the origin of chiral molecules in the prebiotic world. Speculations such as these have drawn a great deal of attention towards chiral crystals. In our lab we are breaking mirror-symmetry and creating chiral crystals of only one handedness (homochiral) using a simple grinding technique. More importantly, we are able to steer the direction (or handedness) of mirror-symmetry breaking using chiral additives (e.g. left- or right-handed amino acids). The main objective of this research program is to investigate the phenomenon of directed mirror-symmetry breaking at the molecular level. We will use classic crystal growing techniques and modern instrumental and computational methods to study the interactions of chiral molecules with chiral crystals. Not only does this research have exciting implications regarding the origin of homochirality, but the interaction of organic molecules with crystalline materials is a continuously expanding research field for chemists, biochemists, and biologists (e.g. formation of bones, teeth, kidney stones and shells). Our work on chiral crystal grinding, may provide important insight into polymorphism and co-crystallization that play critical roles in the solid-state properties of pharmaceuticals.